Donanemab for reducing the risk of mild cognitive impairment in preclinical Alzheimer's disease [ID6675]

Status:

Topic prioritisation

Technology type:

Medicine

Decision:

Awaiting decision

ID number:

6675

Project Team

Project lead

Danielle Lees

Timeline

Key events during the development of the guidance:

For further information on how we select topics for development, please see our page about topic prioritisation